Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.
|
24107997 |
2013 |
Systemic Scleroderma
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis.
|
21160034 |
2011 |
Systemic Scleroderma
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
In this issue of Science Translational Medicine, a report by Loeys et al. on mutations in the fibrillin-1 gene in patients with skin fibrosis (stiff skin) adds a new piece of information on a connective tissue disorder that resembles systemic sclerosis, an autoimmune disease characterized by skin fibrosis and visceral organ involvement.
|
20375002 |
2010 |
Systemic Scleroderma
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome.
|
20375004 |
2010 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
BEFREE |
In contrast with data from Choctaw and Japanese patients, no association was detected between the polymorphic markers of FBN1 and SSc in 2 European Caucasian populations.
|
18278837 |
2008 |
Systemic Scleroderma
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
To better understand the molecular basis of dermal fibrosis in SSc, we analyzed microarray gene expression in skin of the Tight-skin (Tsk) mouse, an animal model where skin fibrosis is caused by an in-frame duplication in fibrillin-1 (Fbn-1).
|
17943183 |
2008 |
Systemic Scleroderma
|
0.300 |
AlteredExpression
|
disease |
LHGDN |
Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.
|
16802364 |
2006 |
Systemic Scleroderma
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.
|
16802364 |
2006 |
Systemic Scleroderma
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
These data indicate that anti-fibrillin-1 autoantibodies can induce the activation of normal dermal fibroblasts into a profibrotic phenotype resembling that of SSc by potentially causing the release of sequestered TGF-beta1 from fibrillin-1-containing microfibrils in the ECM.
|
16177099 |
2005 |
Systemic Scleroderma
|
0.300 |
GeneticVariation
|
disease |
LHGDN |
Fibrillin 1 abnormalities in dermal fibroblast cultures from first-degree relatives of patients with systemic sclerosis (scleroderma).
|
14730633 |
2004 |
Systemic Scleroderma
|
0.300 |
GeneticVariation
|
disease |
LHGDN |
Examination of the possible role of biologically relevant genes around FBN1 in systemic sclerosis in the Choctaw population.
|
14613297 |
2003 |
Systemic Scleroderma
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Subsequently, studies of FBN1 single nucleotide polymorphisms (SNPs) demonstrated that certain FBN1 haplotypes were associated with SSc in both Native American and Japanese patients with limited scleroderma.
|
12384286 |
2002 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.
|
11168809 |
2001 |
Systemic Scleroderma
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
These same FBN1 SNP haplotypes were associated with SSc in the Japanese.
|
11315929 |
2001 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
BEFREE |
The majority of Choctaw American Indians, Japanese, and African Americans with SSc produced IgM and/or IgG autoantibodies to one or more recombinant fibrillin 1 proteins, while <50% of Caucasians with SSc showed seroreactivity.
|
11083269 |
2000 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
The Tight skin mouse: demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils.
|
9490728 |
1998 |
Systemic Scleroderma
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population.
|
9778214 |
1998 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Increased alpha 1(I) procollagen gene expression in tight skin (TSK) mice myocardial fibroblasts is due to a reduced interaction of a negative regulatory sequence with AP-1 transcription factor.
|
7721853 |
1995 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse.
|
7783425 |
1995 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Cardiac collagen changes during the development of right ventricular hypertrophy in tight-skin mice with emphysema.
|
8070538 |
1994 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Tight-skin mouse an experimental model for scleroderma.
|
7523551 |
1994 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Tight-skin mouse autoantibody repertoire: analysis of VH and VK gene usage.
|
7688852 |
1993 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Increased collagen synthesis and increased content of type VI collagen in myocardium of tight skin mice.
|
8221765 |
1993 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Granulated metrial gland cells in the pregnant uterus of mice expressing the collagen mutation tight-skin (Tsk/+).
|
1617705 |
1992 |
Systemic Scleroderma
|
0.300 |
Biomarker
|
disease |
MGD |
Urinary bladder function in the tight-skin mouse.
|
1433576 |
1992 |